Oncology

Download Brochure


Oncology

Cancer known medically as a malignant neoplasm, is a broad group of various diseases, all involving unregulated cell growth. In cancer, cells divide and grow uncontrollably, forming malignant tumours, and invade nearby parts of the body. The cancer may also spread to more distant parts of the body. There are over 200 different known cancers that afflict humans. Cancer is the subject of widespread fear and taboos. There is a deep belief that cancer is necessarily a difficult and usually deadly disease.

Shilpa offers a comprehensive, high-quality portfolio and a dynamic pipeline of oncology drugs, which are beyond standard generics. We have a broad portfolio of 25 + products and a robust pipeline that addresses the needs of cancer treatment. By further growing our portfolio and strengthening our global presence, Shilpa will ensure that patients worldwide have greater access to a comprehensive range of these vital quality medicines at an affordable cost. We are proud to assert that the field of Oncology is one of our core competencies and we offer a comprehensive range of APIs and Finished Dosage Forms in this segment.

For more information on Shilpa‘s pipeline/products to treat cancer, Please find below Oncology product list.

Oncology API’s

Oncology API Tech Pack DMF Status
Open Part US EU TPD PMDA TGA EDQM KFDA GCC Medsafe
Anastrozole                    
Azacitidine                  
Bendamustine                
Bicalutamide              
Bortezomib              
Busulphan              
Cabazitaxel Amorphous                    
Capecitabine        
Carboplatin                  
Cladribine                    
Clofarabine                    
Cyclophosphamide                    
Cytarabine                    
Dasatinib Monohydrate                    
Decitabine                  
Docetaxel                    
Erlotinib                    
Gemcitabine HCl    
HydroxyUrea                    
ImatinibMesylate                  
Irinotecan HCl Trihydrate        
Lenalidomide                    
Letrozole                  
Melphalan                    
Oxaliplatin      
Paclitaxel                    
Pazopanib                    
Pemetrexed Disodium Hemipentahydrate                
Pemetrexed DiPotassium                    
Sorafenib Tosylate                    
Sunitinib                    
Temozolomide        
Thalidomide                    
TopotecanHCl                    
Vismodegib                    
Zoledronic acid                  
5- Fluoro Uracil                    

Under Development-Oncology API’s

PRODUCTS UNDER DEVELOPMENT (Oncology)
Abiraterone Acetate Axitinib
Bosutinib Crizotinib
Enzalutamide Estramustine
Exemestane Gefitinib
LapatinibDitosylate Nilotinib
Procarbazine Pralatrexate
Regorafenib Temsirolimus
Vemurafenib  

* PRODUCTS UNDER VALID PATENTS ARE NOT OFFERED FOR COMMERCIAL OPERATIONS:
ONLY R&D QUANTITIES ARE OFFERED.

For Enquiries, please contact

Shilpa Medicare Limited

10/80, Rajendra Gunj, Raichur – 584 102 (India)
Tel: +91-8532-235006, Fax: +91-8532-235876
eMail: info@vbshilpa.com, vishnu@vbshilpa.com